The Scottish Government has confirmed a series of important amendments to the Pharmacy First remuneration model, along with the creation of a new Pharmacy First Plus activity pot to support independent prescriber (IP) activity in community pharmacies.
The changes, outlined in NHS Circular PCA (P)(2025) 24, will take effect from 1 November 2025 and represent the first phase of a wider redevelopment of the service, which will see a new specification published in 2026.
Adjustments to Weightings on PGDs
From November, the weighting for Patient Group Direction (PGD) advice and referral activity within NHS Pharmacy First Scotland will remain at 1, with treatment now being weighted at 5 (previously 3).
Pharmacy teams are reminded of their role in supporting the Antimicrobial Resistance Action Plan, ensuring antibiotic supply only when clinically necessary and continuing to claim for “advice only” and “referral” outcomes to support service monitoring.
Pharmacy First Activity Changes
The Scottish Government has also introduced an upper activity threshold to ensure a fairer distribution of existing funding across all pharmacies. Under this change, if a pharmacy’s activity exceeds 1,000 in a calendar month, each activity point beyond that threshold will be valued at 0.1. The calculation will include all claims for advice, referral and treatment, both within the standard Pharmacy First service and PGD consultations as well as advice and referral claims for the Pharmacy First Plus independent prescribing service.
Activity will be monitored over the six months following implementation to assess whether the change has achieved its intended effect, with a review planned afterwards.

New Remuneration Model for Independent Prescribers
Contractors who have Independent Prescribers (IP) will continue to receive the existing £3,000 monthly base payment for each full month the service is provided. Contractors who are unable to offer the service for at least 25 hours per week over 45 weeks a year can still deliver Pharmacy First Plus consultations but will not be eligible for the base payment.
A key addition is the introduction of a new activity-based remuneration pot for IP prescribing, initially valued at £0.5 million per month. There will be no minimum activity threshold to access this pot.
Eligible claims include prescriptions written on NHS Board-issued IP pads for:
- Prescription Only Medicines (POMs)
- Pharmacy (P) or General Sales List (GSL) products not listed on the approved NHS PFS list
- P or GSL products used outwith their licensed restrictions
The activity fee will range between £30 and £40 per intervention, with the model scheduled for implementation in December 2025.
Contractors will receive payments for activity carried out in December, along with retrospective payments for eligible work from November.
To ensure full delivery of the 2025 to 2026 funding, a one-off balancing payment will also be distributed for October 2025 based on dispensing pool allocations.
Next Steps
All consultations should continue to be recorded through the Universal Claim Framework (UCF), and any treatments using standard Pharmacy First items should now be processed under the standard service module with an additional “Advice Only” claim to indicate IP involvement.
The Scottish Government has confirmed that an updated Pharmacy First Scotland service specification will be published in 2026, consolidating recent changes and setting out the next stage of service development.
These changes have been developed in consultation with Community Pharmacy Scotland and are aimed at ensuring a sustainable and equitable model that reflects the expanding clinical role of pharmacists across Scotland.
The Community Pharmacy Scotland (CPS) team will run a webinar on the detail of the circular on the evening of the 20th of November. In the meantime, if you have any questions please contact enquiries@cps.scot. You can register your interest here.






